How to buy Bio-Rad Laboratories stock (BIO)

Bio-Rad Laboratories is a medical devices business based in the US. Bio-Rad Laboratories shares (BIO) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $328.59 – a decrease of 3.31% over the previous week. Bio-Rad Laboratories employs 8,000 staff and has a trailing 12-month revenue of around $2.6 billion.

Our top picks for where to buy Bio-Rad Laboratories stock

Buy Bio-Rad Laboratories stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Bio-Rad Laboratories stock price (NYSE: BIO)

Use our graph to track the performance of BIO stocks over time.

Bio-Rad Laboratories shares at a glance

• Key figures

Information last updated 2024-10-24.

Latest market close	$328.59
52-week range	$261.59 - $364.24
50-day moving average more info button	$331.05
200-day moving average more info button	$314.40
Wall St. target price	$381.83
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-46.36

Is it a good time to buy Bio-Rad Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bio-Rad Laboratories price performance over time

Historical closes compared with the close of $320.23 from 2024-10-25

1 week (2024-10-22)	-5.77%
1 month (2024-09-27)	-3.48%
3 months (2024-07-29)	-1.66%
6 months (2024-04-29)	15.56%

1 year (2023-10-27)	18.31%
2 years (2022-10-28)	-9.62%
3 years (2021-10-25)	N/A
5 years (2019-10-29)	337.92

Is Bio-Rad Laboratories stock undervalued or overvalued?

Valuing Bio-Rad Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bio-Rad Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bio-Rad Laboratories's PEG ratio

Bio-Rad Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1905. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bio-Rad Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Bio-Rad Laboratories's EBITDA

Bio-Rad Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $514.2 million.

The EBITDA is a measure of a Bio-Rad Laboratories's overall financial performance and is widely used to measure a its profitability.

Bio-Rad Laboratories financials

Revenue TTM	$2.6 billion
Operating margin TTM	15.74%
Gross profit TTM	$1.6 billion
Return on assets TTM	2.11%
Return on equity TTM	-17.41%
Profit margin	-51.73%
Book value	$240.39
Market Capitalization more info button	$9.3 billion

TTM: trailing 12 months

Bio-Rad Laboratories share dividends

We're not expecting Bio-Rad Laboratories to pay a dividend over the next 12 months.

Have Bio-Rad Laboratories's shares ever split?

Bio-Rad Laboratories's shares were split on a 2:1 basis on 7 March 2002 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bio-Rad Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bio-Rad Laboratories shares which in turn could have impacted Bio-Rad Laboratories's share price.

Bio-Rad Laboratories share price volatility

Over the last 12 months, Bio-Rad Laboratories's shares have ranged in value from as little as $261.59 up to $364.24. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bio-Rad Laboratories's is 0.947. This would suggest that Bio-Rad Laboratories's shares are less volatile than average (for this exchange).

Bio-Rad Laboratories overview

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc.

Frequently asked questions

null
What percentage of Bio-Rad Laboratories is owned by insiders or institutions?
Currently 15.662% of Bio-Rad Laboratories shares are held by insiders and 89.11% by institutions. How many people work for Bio-Rad Laboratories?
Latest data suggests 8,000 work at Bio-Rad Laboratories. When does the fiscal year end for Bio-Rad Laboratories?
Bio-Rad Laboratories's fiscal year ends in December. Where is Bio-Rad Laboratories based?
Bio-Rad Laboratories's address is: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 What is Bio-Rad Laboratories's ISIN number?
Bio-Rad Laboratories's international securities identification number is: US0905722072 What is Bio-Rad Laboratories's CUSIP number?
Bio-Rad Laboratories's Committee on Uniform Securities Identification Procedures number is: 090572207